The identification of these new recurrent genetic mutations in melanomas and the lack of identified driver mutations in the melanoma subtypes lacking BRAF and NRAS mutations indicate that our understanding of the genetic alterations driving this malignancy remains incomplete. The gene discussed is NRAS; the disease is melanoma.